Literature DB >> 31454037

PD-L1 Status and Survival in Patients With Lung Cancer-Reply.

Peter Grant Miller1, Gerald Li2, Gaurav Singal2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31454037     DOI： 10.1001/jama.2019.9196

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma.

Authors:  Dijian Shen; Jiangfeng Wang; Jie Wu; Sheng Chen; Jianqiang Li; Jinshi Liu; Qixun Chen; Youhua Jiang
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.